09:41 EST Tempest Therpeutics trading halted, volatility trading pause
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPST:
- Tempest announces acquisition of new dual-CAR T programs from Factor Bioscience
- Tempest Therapeutics Reports Q3 2025 Financial Results
- Tempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year
- TPST Earnings this Week: How Will it Perform?
- Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment